Jim Cramer says this former Covid market darling is finally investable again
Moderna's expanding pipeline beyond infectious diseases is giving investors a new reason to own the stock after years of uncertainty...
HEALTH & FITNESS
Walmart, CVS step in to help seniors
A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to...
Cramer says this stock is significantly undervalued, sees 35% upside
Every weekday, the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. ET. Here's a...
FDA allows Philip Morris-owned Zyn marketed as less harmful cigarettes
In this photo illustration, Zyn nicotine cases are seen on a table on Jan. 29, 2024, in New York City.Michael...
Eli Lilly, Regeneron in FDA PreCheck manufacturing program
Eli Lilly and Regeneron are among the first seven companies the U.S. Food and Drug Administration selected for a pilot...
Chan Zuckerberg Biohub to open new rare disease funding round
Priscilla Chan (R) and her husband Mark Zuckerberg announce the Chan Zuckerberg Initiative to "cure, prevent or manage all disease"...
This life sciences stock has a secret weapon, and AI will only make it more valuable
IQVIA, with its vast trove of health information, sits at the center of drug development, providing data, tools and services...
Red alerts issued in UK, France, Spain and Italy
An empty street in Toulouse, France, on June 22, 2026. France experiences its second heatwave of the year, with temperatures...
UPS to invest $48 million in cold facilities amid GLP-1 boom
United Parcel Service (UPS) trucks are parked at a UPS drop yard on Oct. 28, 2025 in Vernon, California.Mario Tama...
U.S. opens tariff probe targeting Germany’s drug pricing policies
The U.S. has launched an investigation into Germany's pharma policies over what it referred to as "persistent underpayment" for medicines...
Huntington’s disease drugmaker UniQure to seek FDA OK for gene therapy
Thomas Fuller | SOPA Images | Lightrocket | Getty ImagesUniQure plans to seek FDA approval of its experimental gene therapy...
Biotech IPO window is open but big pharma M&A sets the pace: Bankers
Public markets are beginning to reopen for biotech companies after several years of muted activity. But the strongest companies may...
CVS Health executives on reducing healthcare’s biggest pain points
Nikolas Kokovlis | Nurphoto | Getty ImagesA version of this article first appeared in CNBC's Healthy Returns newsletter, which brings...
Rollins called screwworm a ‘little pest.’ Last year, she said ‘terrifying’
Agriculture Secretary Brooke Rollins told CNBC on Monday that the new world screwworm is a "little pest." In the past,...
What screwworm in cattle herds means for beef prices this summer
Cattle roam a field on June 6, 2026 in La Pryor, Texas.Joel Angel Juarez | Getty ImagesThe arrival of the...
Why drug development is heading to orbit
The highly anticipated SpaceX mega-IPO is part of a space frenzy that is moving beyond satellite connectivity, launch vehicles, and...
GSK in talks to acquire Nuvalent for more than $9 billion
GlaxoSmithKline headquarters in London on Jan. 17, 2022.Hannah Mckay | ReutersUK pharmaceutical group GSK is in talks to acquire oncology...
Jim Cramer says he can’t sell Eli Lilly despite its massive run up. Here’s why
Eli Lilly 's expanding obesity drug pipeline is giving us little reason to take profits at this point — even...
Texas screwworm cases don’t risk food supply, Brooke Rollins says
The U.S. food supply is "not at risk" from the return of the flesh-eating screwworm parasite to Texas, U.S. Department...
Weight loss drug maker stock sinks 25% as safety data spooks investors
Shares of weight loss drug maker Zealand Pharma plummeted as much as 26% on Monday after new data on its...
